In conclusion, the authors mention that all patients with coronal craniosynostosis should be tested for the pathogenic variant p.Pro250Arg in the FGFR3 gene, to confirm the diagnosis of MS. This evidence concerns the gene FGFR3 and myeloid sarcoma.